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Abstract
Rapeseed  is  one of the world’s major oilseeds, and rapeseed oil is produced by pressing of the seeds. This process 
results in the production of a low-economic-value by-product, rapeseed meal, which is commonly used as animal feed. 
Rapeseed meal is rich in bioactive phenolic compounds, including sinapinic acid (SA) and protocatechuic acid (PCA). 
Isolation of these bioactive compounds from a by-product of rapeseed oil production is largely in agreement with the 
current concept of the circular economy and total utilisation of crop harvest using a biorefinery approach. In this review, 
current information concerning traditional and novel methods to isolate phenolic compounds – including SA and PCA – 
from rapeseed meal, along with in vitro and in vivo studies concerning the bioactivity of SA and PCA and their associated 
health effects, is collated. These health effects include anti-inflammatory, anti-cancer, anti-diabetes activities, along with 
histone deacetylase inhibition and protective cardiovascular, neurological and hepatic effects. The traditional extraction 
methods include use of solvents and/or enzymes. However, a need for simpler, more efficient methodologies has led to 
the development of novel extraction processes, including microwave-assisted, ultrasound-assisted, pulsed electric field 
and high-voltage electrical discharge extraction processes.
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Introduction
Rapeseed is a globally valuable crop, and its production has 
steadily grown over the past 20 yr. Rapeseed is cultivated 
in China, India, Canada and Europe; however, in terms of 
rapeseed production, Europe is the largest producer (Carre, 
2014). In the year 2013/2014, the European Union (EU) 
produced 9.93 million t of rapeseed oil, while China produced 
6.58 million t (List, 2015). A by-product of the rapeseed oil 
industry, rapeseed meal contains bioactive constituents, 
such as the phenolics sinapinic acid (SA) and protocatechuic 
acid (PCA), which have potential uses as functional food 
ingredients and for use in cosmetic and pharmaceutical 
applications. Improving and developing methods to isolate 
phenolic compounds from rapeseed meal could enhance the 
economic value of this resource. The isolation of phenolics 
from rapeseed meal encompasses the idea of a “circular 
economy”, whereby resources that would otherwise be 
considered waste are recycled into products (Velis, 2015). 
Traditional methods of isolating phenolics from rapeseed 
meal include organic solvent and enzymatic extraction; 
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however, this can require large volumes of solvent, while the 
associated toxicity of certain organic solvents such as methanol 
makes them unsuitable for use in final food applications. This 
has encouraged the development of novel isolation methods 
such as ultrasound-assisted (UAE), microwave-assisted (MAE), 
high-voltage electrical discharge (HVED) and pulsed electric field 
(PEF) extraction processes (Teh and Birch, 2014; Barba et al., 
2015; Teh et al., 2015). In the first part of this review, existing 
and novel methods of isolating these phenolic compounds from 
rapeseed meal are examined. The second part of the review 
focusses on the diverse bioactive properties of these phenolics, 
which could make them potentially useful in improving human 
health.
Poor diet plays a role in the development of major diseases such 
as heart disease, diabetes and cancer. Consumption of a diet 
rich in vegetables is strongly implicated as a protective factor 
against such diseases, due to the presence of polyphenols or 
phenolic compounds. Clinical trials regarding the use of dietary 
phenolic compounds for the prevention of colorectal cancer 
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Phenolic compounds in rapeseed
Rapeseed is reported to contain more phenolic compounds 
than any other oilseed plant (Lomascolo et al., 2012). 
Reports suggest that rapeseed contains 240–590 μg/g of 
SA, while rapeseed cake (an initial by-product produced by 
crushing the rapeseeds to remove the oil) contains 170–
454 μg/g of SA (Nićiforović and Abramovič, 2014). PCA is 
also found in rapeseed, with concentrations ranging from 28 
μg/g to 612 μg/g in rapeseed hulls (Liu et al., 2012). Phenolic 
compounds present in rapeseed can be categorised into 
various subgroups: phenolic acids, lignans, stilbenes, 
flavonoids, isoflavonoids and complex phenolic polymers 
such as tannins (Vuorela, 2005). Phenolic acids tend to be 
found in a soluble form, conjugated with sugars or organic 
acids, and are usually constituents of more complex structures 
such as lignans and hydrolysable tannins (Cheynier et al., 
2013). In rapeseed, the main phenolic compounds are 
derivatives of hydroxycinnamic acid (Cvjetko. et al., 2009). 
The biosynthetic origin of both benzoic and cinnamic acid 
derivatives is the aromatic amino acid l-phenylalanine, 
which itself is the end product of the shikimate pathway. 
The preceding conversion of l-phenylalanine to various 
hydroxycinnamic acids involves a three-step sequence, 
referred to as the “general phenylpropanoid metabolism” 
(Robbins, 2003). Phenolic compounds found in rapeseed 
mainly exist in the esterified form. Sinapine, which is the 
choline ester of SA, is the main phenolic ester in rapeseed. 
revealed that the amount required to exert their effects exceeds 
what is obtainable from dietary intake alone (Nunez-Sanchez 
et al., 2015). In this review, diverse and potentially important 
physiological roles of SA and PCA in terms of human health 
and disease are discussed.
Rapeseed meal and oil production
Rapeseed meal is a by-product of the rapeseed de-oiling 
process, with the majority of phenolic compounds remaining 
in the meal after extraction of the oil (Figure 1). Traditionally, 
the production of rapeseed oil involves mechanical extraction 
by pre-pressing and extrusion of rapeseeds, followed by 
extraction with solvents such as food grade hexane. The 
processing of oil and meal involves various steps, including 
seed pre-conditioning and flaking, seed cooking, pressing 
and solvent extraction, followed by the removal of solvent 
and toasting. Some small-scale facilities do not use solvents 
to extract rapeseed oil, using only mechanical extraction 
(Booth, 2004). Although food grade solvents are used during 
extraction of food grade oils, further refinement of the rapeseed 
oil is necessary to make it more palatable and suitable for 
human consumption. Refinement steps include the removal of 
unwanted components, including phospholipids and free fatty 
acids, which can be achieved by either physical or chemical 
means. Chemical methods include either water or acid 
degumming and alkali refining, while the physical process 
involves “steam distillation”.
Figure 1. Rapeseed de-oiling process and the phenolics remaining in the meal after extraction.
106
Irish Journal of Agricultural and Food Research
Sources and structure of PCA
PCA is chemically known as 3,4-dihydroxybenzoic acid. This 
compound is purported to have various pharmacological 
activities, including anti-inflammatory, anti-cancer and 
cardiac beneficial activity. It is frequently detected in edible 
plants used in folk medicine and is one of the suggested 
biologically active components in medicinal plants such as 
Sudan Mallow (Hibiscus sabdariffa L.) and St. John’s wort 
(Hypericum perforatum L.) (Kakkar and Bais, 2014). It is also 
found in common fruits and vegetables, such as blackberries, 
blackcurrant, cauliflower and lentils (Masella et al., 2012). 
PCA is a major metabolite of other complex polyphenols, such 
as the anthocyanins. Anthocyanins are mainly found in fruits 
such as those of the berry family, pomegranate and pigmented 
varieties of oranges (e.g. Tarocco, Moro and Sanguinello). 
In humans and animals, anthocyanins are absorbed as 
intact glycosides and metabolites. While they can undergo 
methylation and glucuronidation, they primarily undergo 
degradation, followed by considerable phase II conjugation, 
particularly methylation and sulphation. De Ferrars et al. 
(2014) studied the metabolism of the anthocyanin cyanidin-
3-glucoside and found that it spontaneously degrades to PCA 
in the small intestine and the circulation (De Ferrars et al., 
2014).
Traditional extraction processes for recovering 
phenolics from rapeseed meal
Traditionally, extraction of phenolic acids involves a de-
fatting step to remove excess oil. This is usually performed 
with hexane in a Soxhlet apparatus, with the use of food 
grade hexane important if the product is to be utilised in food 
applications. Phenolics found in rapeseed can be divided 
into three categories: (1) free phenolic acids, (2) soluble 
esters and (3) insoluble-bound phenolics (Naczk et al., 
1992; Szydłowska-Czerniak et al., 2010). Solvents used to 
extract these phenolics include methanol, ethanol, acetone 
or a combination of these (e.g. methanol: acetone: water 
7:7:6) (Naczk et al., 1992; Cai and Arntfield, 2001; Khattab 
et al., 2010; Liu et al., 2012). Free phenolic acids can be 
extracted using methanol: acetone: water (7:7:6, v:v:v) 
solvent system, and the soluble esters can be obtained 
through hydrolysis with sodium hydroxide or enzymes and 
subsequently extracted with diethyl ether: ethyl acetate (1:1, 
v:v) (Naczk et al., 1992). Extraction and hydrolysis can also 
be performed with enzymes, such as Ultraflo L and ferulic 
acid esterase (Vuorela et al., 2003). The main compound 
released using enzymatic extraction is SA, with a study by 
However, SA can also be esterified to other phenolic acids, 
sugars or kaempferols (Vuorela, 2005). SA comprises 
70%–96% of the esterified phenolic acids in rapeseed meal, 
while PCA is present in small quantities in rapeseed flours 
(Shahidi and Naczk, 1992). Sinapine plays an important 
role in rapeseed, acting as storage for both SA and choline 
in young plants (Kozlowska et al., 1990). As the seeds 
mature, some of the sinapine is enzymatically hydrolysed 
by sinapine esterase to choline and free SA (Tzagoloff, 
1963). Apart from the esterified forms, free phenolic acids 
can also be found in rapeseed, comprising up to 15% of the 
total phenolics in rapeseed meal. SA comprises 65%–85% 
of free phenolic acids in defatted rapeseed meals, with PCA 
also present in small quantities (Naczk et al., 1992; Shahidi 
and Naczk, 1992; Vuorela, 2005).
Sources and derivatives of SA
SA is found in varying amounts primarily among citrus 
fruits. For example, lemon and Murcott orange are known 
to contain the highest quantities of SA in comparison to 
other natural sources. Additionally, cereal grains such 
as rye and rice are also known to contain substantial 
concentrations of SA, while it has also been shown to be 
present in various herbs such as sage and thyme. SA and 
its derivatives are particularly abundant among the different 
varieties of Brassica vegetables, including rapeseed, kale, 
white cabbage, turnip and broccoli (Table 1). In terms 
of its structure, SA is 3, 5-dimethoxy-4-hydroxycinnamic 
acid, which is found either in free or esterified form. The 
most common glycoside of SA is 1-O-β-d-glucopyranosyl 
sinapate, which can be found in numerous Brassicaceae 
species. SA can also form dimers with itself and ferulic 
acid in the walls of cereal cells, with C8–C8-coupled SA 
dehydrodimers and three sinapate-ferulate heterodimers 
discovered in various insoluble and soluble cereal grain 
dietary fibres. SA in rapeseed also exists as the glucosidic 
ester, glucopyranosyl sinapate. SA does not usually 
exist in free form, and <16% of SA is present as free SA. 
Moreover, 4-vinylsyringol, which is found in crude rapeseed 
oil, is a decarboxylation product of SA. During rapeseed oil 
extraction, elevated temperatures and pressures cause SA 
to undergo structural changes, resulting in the formation of 
4-vinylsyringol, a decarboxylation product of SA, along with 
syringaldehyde. The amount of SA derivatives (which include 
sinapoyl glucose, methyl sinapate, sinapoyl malate and 
1-sinapoyl-2-feruloylgentiobiose) found in rapeseed ranges 
between 6,390 and 18,370 μg/g, but this is dependent on 
the method used to process the oil (Lomascolo et al., 2012; 
Nićiforović and Abramovič, 2014).
107
Quinn et al.: Benefits of sinapinic and protocatechuic acids
walls and release of the bioactive contents (Khoddami 
et al., 2013). Teh and Birch (2014) previously determined 
the optimal parameters to extract phenolics from de-
fatted canola seed cakes to comprise a 200 W ultrasound 
extraction with a solvent volume of 50 mL, extraction time of 
20 min, and temperature of 70°C. This method was found to 
be advantageous over traditional methods in that it involves 
low cost, has low solvent consumption and increases the 
antioxidant activity of the extracts (Teh and Birch, 2014). Other 
protocols have demonstrated UAE to be a suitable technique 
to extract phenolics from rapeseed and related species. An 
optimised protocol for the UAE of antioxidant compounds, 
including phenolics, from rapeseed cultivars was previously 
described by Szydłowska-Czerniak and Tułodziecka (2014). 
They concluded that the optimal conditions to perform UAE 
were an extraction time of 13.8 min, a solvent-to-material 
ratio of 26.2 mL/g and a solvent concentration of 50.3% 
(Szydłowska-Czerniak and Tułodziecka, 2014). Another 
study investigated the optimal UAE conditions to extract 
phenolics from kale, which is a member of the Brassicaceae 
family, along with rapeseed. They determined that the 
optimal conditions were 80% ethanol, with an extraction 
time of 60 min, ultrasound frequency of 20 kHz and power of 
100 W (Oniszczuk and Olech, 2016). Dubie et al. (2013) also 
extracted phenolic antioxidant compounds from mustard 
(Brassica juncea) seed meal, another member of the 
Brassicaceae family, using UAE. They determined that the 
optimal conditions were 75°C for 20 min with 70% ethanol 
and a solvent-to-meal ratio of 40:1, with 20 kHz and 0.5 W/
mL ultrasound treatments using a Branson Sonifier probe 
with input power of 400 W (Dubie et al., 2013).
MAE process
MAE of phenolics from rapeseed meal offers advantages, 
including shorter extraction times and greater yields, over 
traditional methods such as solvent extraction. Teh et al. 
(2015) investigated MAE of phenolics from rapeseed cakes. 
The optimal parameters for MAE of rapeseed cakes were 
found to be 5 min, with a liquid: solvent ratio of 6 mL/g 
and power of 633.33 W. Microwave pre-treatment using 
the optimal parameters described maximised the phenolic 
yield from rapeseed cake when subsequently extracted with 
ultrasound and methanol: acetone: water mixture (7:7:6, 
v:v:v). This method was economically viable due to the 
shorter extraction time, moderate microwave power and low 
electroporation voltage and frequency (Teh et al., 2015). MAE 
has also been used in the extraction of phenolic compounds 
from broccoli, which is a member of the Brassicaceae (or 
mustard) family along with rapeseed. The optimal conditions 
were determined to be 71.11°C, microwave power of 
167.03 W, solvent concentration (methanol/water) of 75.95% 
and an extraction time of 16.34 min (Jokić et al., 2012). Other 
Vuorela (2005) revealing that enzymatic extractions yielded 
a higher total phenolic content compared to solvent-based 
extractions. Enzymes are also useful agents for isolation 
in that they are considered food-friendly, which makes the 
isolated compounds suitable for food applications (Vuorela, 
2005).
Limitations of solvent extraction
Given the shift towards “green and sustainable” methods to 
extract bioactive compounds, reducing or eliminating solvent 
use is a key factor when developing new methodologies. 
This is due to the harmful properties of organic solvents; they 
are flammable, volatile and toxic, while they may also cause 
environmental pollution (Chemat et al., 2012). The use of 
organic solvents also poses problems in terms of using the 
extracted compounds in food applications. In order for SA 
and PCA to be used as food components, the solvents used 
to extract them must be food grade and have safe status. 
If solvents with toxic properties are used in the extraction 
process, they must be removed to a specified residual 
level in order to be eligible for use in food applications, 
e.g. 5–30 mg of hexane/kg of product (such as edible oils) 
(Starmans, 1996).
Novel extraction processes for recovering pheno-
lics from rapeseed meal
Developing novel methods to isolate phenolic compounds 
from rapeseed meal not only overcomes the issues 
associated with the use of solvents but also closely links 
with the biorefinery concept. Efficient, simpler and more 
economic methods of isolation allow for the utilisation of 
rapeseed by-products and ensure total utilisation of the crop, 
with no or limited waste generation (Chemat et al., 2012). 
Various novel methods to extract phenolic acids from various 
natural product sources have been carried out to date, 
including UAE, MAE, HVED and PEF extractions (Teh and 
Birch, 2014; Barba et al., 2015; Teh et al., 2015).
UAE process
UAE provides a unique advantage over traditional methods 
of extraction in that it can overcome physical barriers, such 
as poor solubility of phenolics in rapeseed cake, which can 
make extraction difficult. These physical barriers arise as 
phenolics in the cake are encompassed in lignin, hulls and 
cell walls, which are insoluble structures. This, along with 
the fact that phenolic acids, including SA, occur as esters, 
glycosides and insoluble-bound forms, has hindered their 
extraction from rapeseed cake. Ultrasound generates sound 
waves that create “cavitation bubbles” close to the sample 
tissue; this leads to the breakdown and disruption of cell 
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polyphenol content was observed using a liquid-to-solvent 
ratio of 20, while a liquid-to-solvent ratio of either 5 or 20, 
combined with HVED treatment at 80 kJ/kg also resulted in 
increased polyphenol content. However, it was noted that 
higher energy inputs >80 kJ/kg in rapeseed cake led to a 
decrease in polyphenol content. The authors suggest that 
high-energy inputs result in the creation of radicals, which in 
turn decrease the polyphenol content (Barba et al., 2015). 
Crucially, it was found that the extracts from rapeseed 
cake had a significant increase in their antioxidant activity 
following HVED treatments. Other studies have shown the 
efficacy of this technique to extract phenolics from different 
oilseed sources, including sesame cake and flaxseed cake 
(Boussetta et al., 2013; Sarkis et al., 2015). The study by 
Barba et al. was an initial optimisation, in addition to being 
the first step in the search for more efficient methods to 
isolate phenolic compounds from rapeseed by-products. 
Further optimisation and validation are necessary in order 
to ensure the efficacy of this novel technique; however, it is 
worthy of mention due to its proven ability to extract phenolic 
compounds and its apparent efficiency over traditional 
methods, such as lower solvent consumption.
Characterisation strategies for rapeseed meal 
phenolics
As SA and PCA found in rapeseed possess various bioactive 
properties, including anti-inflammatory, anti-diabetes and 
anti-cancer activities, they are of interest as functional food 
components (Cherng et al., 2013; Del Corno et al., 2014; Tsao 
et al., 2014). Therefore, further separation and purification are 
necessary to isolate these phenolic compounds from the initial 
fractions. Initially, the total phenolic content is often quantified 
using the Folin-Ciocalteu assay (Vuorela, 2005). Chemical 
characterisation and quantification are commonly performed 
using high-performance liquid chromatography (HPLC) or 
gas–liquid chromatography (GLC)/gas chromatography–mass 
spectrometry (GC-MS) (Cai and Arntfield, 2001; Canini et al., 
2007; Khattab et al., 2010). HPLC is the preferred method 
for separation and quantification of phenolic compounds 
due to the fact that there is a wide range of commercially 
available columns, as well as the potential to combine two 
or more columns with differing column chemistries (Stalikas, 
2007). However, despite the fact that HPLC is a commonly 
used technique, it has been suggested that GC-MS is 
more efficient, providing improved resolution and baseline 
separation with minimum co-elution. It must also be noted 
that when quantifying phenolic compounds with GC, there is 
sometimes a requirement for chemical modification, such as 
transformation to more volatile derivatives (Khoddami et al., 
2013).
studies have demonstrated the efficacy of this technique 
in the extraction of phenolics, although from different 
sources, including rice grains and almond skin by-products 
(Setyaningsih et al., 2015; Valdés et al., 2015). The success 
of this technique in extracting phenolic compounds means 
it could be a useful method to isolate phenolic compounds 
from rapeseed meal, but further optimisation and validation 
are necessary.
PEF extraction
PEF extraction is a process that does not require heat but 
generates an electric field, which results in the electroporation 
of the cellular membrane and the release of the bioactive 
constituents from the “protoplasm”. The efficacy of this 
technique depends on various factors, including the strength 
of the electric field as well as the duration and number 
of pulses. A recent study (Teh et al., 2015) optimised the 
extraction of polyphenols using PEF from rapeseed cake. 
In order to recover the maximum yield of polyphenols, 
the optimal parameters for PEF extraction were found to 
be as follows: voltage of 30 V, frequency of 30 Hz, 10% 
ethanol and an exposure time of 10 s. This method also 
proved advantageous over traditional methods due to the 
shorter extraction time and low solvent use (Teh et al., 
2015). Yu et al. (2016) evaluated PEF-assisted extraction 
of polyphenols in order to valorise a by-product of rapeseed 
oil production, rapeseed stem or green biomass. They 
determined that the number of pulses that yielded higher 
total polyphenol content of juices pressed at 10 b was 200, 
with a strength of 8 kv/cm. The efficacy of PEF pre-treatment 
was demonstrated by the increase in total polyphenols with 
PEF pre-treatment and subsequent pressing. Without PEF 
pre-treatment, after 30 min of pressing, the result was 24% 
polyphenol yield from rapeseed. PEF pre-treatment with 
200 pulses and an increase in strength to 8 kv/cm resulted 
in maximum polyphenol yield for pressing (Yu et al., 2016). 
These initial studies have had success in isolating phenolics 
from rapeseed by-products, and it could be a promising 
novel method to isolate phenolic compounds; however, 
further studies are necessary to fully validate this method 
for use with rapeseed meal.
HVED approach
HVED is based on “electrical breakdown in water”, which 
is accompanied by various phenomena including high-
amplitude pressure shock waves and cavitation bubbles. 
This subsequently leads to the breakdown of cellular 
structures and the release of the cell contents. The use 
of HVED to isolate polyphenols from rapeseed cake was 
also investigated previously (Barba et al., 2015). The study 
found that when isolating polyphenols from rapeseed cake, 
the liquid-to-solid ratio was a key parameter. The highest 
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and apoptosis (Tortorella et al., 2015). Thus, HDAC inhibitors 
are emerging as potential therapeutic agents. There has 
been success in developing clinical therapeutics using 
HDAC inhibitors from both natural and synthetic sources. For 
example, suberoylanilide hydroxamic acid (SAHA) (vorinostat) 
and the natural product, romidepsin, were both approved for 
the treatment of cutaneous T-cell lymphoma (Mair et al., 2014). 
SA was previously shown to have HDAC inhibitory activity. 
Senawong et al. (2013) extracted phenolic compounds from 
the rhizome of Hydnophytum formicarum Jack, and SA was 
found to be one of the major components. SA was found to 
block HDAC enzyme activity in vitro at a similar concentration 
as the established HDAC inhibitor sodium butyrate, with the 
authors suggesting that SA partly accounted for the HDAC 
inhibitory activity of the phenolic extract. The phenolic extract 
possessing HDAC inhibitory activity was found to inhibit the 
growth of HeLa cells in a dose- and time-dependent manner, 
while SA was also found to significantly inhibit the growth of 
HT-29 cells. The phenolic extract and SA were also found to 
have a significant effect on the induction of apoptosis, up to 
78.9% and 8.4%, respectively.
Anti-cancer and antibacterial activities
SA was found to be cytotoxic against various cancer cell lines, 
including the human colon cancer cell lines HT-29 and SW480 
and the human laryngeal carcinoma Hep-2 cells, when 
assayed previously (Balaji et al., 2014; Janakiraman et al., 
2014). The cytotoxicity is probably due to the anti-proliferative 
activity of SA, which is supported by a study demonstrating 
SA’s anti-proliferative activity against the breast cancer cell 
line T47D (Kampa et al., 2004). The antibacterial effect of 
SA was demonstrated to be anti-carcinogenic, brought about 
by decreasing mucinase activity, an enzyme secreted by gut 
microflora. This inhibited mucin degradation and enhanced 
contact between carcinogens and colon epithelial cells. SA 
also inhibited carcinogenesis by increasing the activities of 
enzymatic and non-enzymatic antioxidants, including SOD, 
catalase (CAT) and GSH, with ROS known to play a role in 
early carcinogenesis. SA could potentially prevent the onset 
of carcinogenesis, as demonstrated in a study by Balaji et al. 
(2015). Colon cancer is the third most common malignancy 
worldwide, with a high-fat diet being a primary risk factor for 
developing colon cancer. Consumption of a high-fat diet has 
been reported to increase the development of pre-neoplastic 
lesions. Aberrant crypt foci (ACFs) are pre-neoplastic lesions, 
which are formed during an early event in carcinogenesis in 
humans and rodents. Rats fed a high-fat diet consisting of 
peanut oil had increased crypt numbers and “multiplicity”. SA 
supplementation in 1,2-dimethylhydrazine (DMH)-induced 
colon cancer rats decreased the development and number 
of ACFs. SA also decreased β-glucuronidase activity in 
DMH-induced rats. Increased β-glucuronidase activity is 
SA and PCA in human health and disease
Properties of SA
Antioxidant activity of SA
SA can modulate oxidative stress pathways in the cell and may 
have potential in treating diabetes and high blood pressure 
(Roy and Prince, 2012; Silambarasan et al., 2015). Oxidative 
stress can be defined as an imbalance in the “redox” status 
of a cell, which occurs when the levels of reactive oxygen 
species (ROS) and antioxidants are unbalanced (Nordberg 
and Arner, 2001). ROS can be found extrinsically in the form 
of pollutants, tobacco smoke and radiation; however, ROS 
may also be generated intrinsically through various pathways 
in the mitochondria (Trachootham et al., 2009). The single 
electron reduction of molecular oxygen leads to the formation 
of a superoxide anion, a molecule that acts as a precursor 
for the formation of most other ROS (Turrens, 2003). In order 
to maintain homeostatic levels of reactive superoxide anions, 
the mitochondrial matrix contains a family of metalloenzymes 
known as superoxide dismutases (SODs). Compounds such 
as ascorbic acid, tocopherols and glutathione (GSH) also 
provide antioxidant activity (Jalaludeen and Pari, 2011). High 
levels of ROS are known to be carcinogenic, damaging vital 
cellular components including lipids, proteins and DNA. Given 
the destructive potential of ROS, it is generally thought that the 
use of antioxidants could reduce intracellular ROS levels and 
thus alleviate ROS-mediated damage (Brieger et al., 2012). 
Recent studies indicate the antioxidant activity of SA and SA’s 
superoxide radical and hydroxyl radical, as well as its –O
2
•-
scavenging activity (Zou et al., 2002; Jalaludeen and Pari, 
2011). Using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, 
it was found that SA had higher free radical-scavenging activity 
than its alkyl ester methyl sinapate or the control Trolox, a 
vitamin E analogue. Ferric reducing antioxidant power (FRAP) 
assays also revealed the higher antioxidant scavenging 
activity of SA compared to its alkyl ester methyl sinapate or 
the control Trolox (Gaspar et al., 2010). The mechanism and 
kinetics of SA’s antioxidant activity were measured using its 
hydroperoxyl radical (HOO•)-scavenging activity in lipidic and 
aqueous solutions, which occurs through the transfer of a 
hydrogen atom from its -OH group. The anionic form of SA at 
physiological pH was also more reactive than its neutral form 
towards oxygenated radicals (Galano et al., 2011).
Histone deacetylase inhibition
Histone deacetylases (HDACs) remove acetyl groups from 
histones, resulting in a “closed” chromatin conformation that 
blocks gene transcription and therefore gene expression. 
Aberrant HDAC activity is common in various cancer types, 
driving carcinogenesis through the repression of genes 
involved in the cell cycle regulation, cellular differentiation 
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of non-enzymatic antioxidants such as the vitamins C and 
E. Ventricular hypertrophy was observed due to l-NAME 
treatment, causing a reduction in contractile function. SA 
treatment restored this ventricular function, which the 
authors attributed to its antioxidant abilities, considering 
that previous studies have shown that oxidative stress 
plays a role in fibrosis during hypertension. Damaged cells 
leak hepatic enzymes such as aspartate aminotransferase 
(AST), alkaline phosphatase (ALP) and gamma-glutamyl 
transferase (GGT), causing an increase in their activities. 
Treatment with SA decreased their activities and controlled 
liver damage, which was validated by histopathological 
examination of the liver. SA was also found to decrease renal 
function markers, including urea, uric acid and creatinine, 
towards normal levels. Epidemiological studies have linked 
hypercholesterolaemia to hypertension. Furthermore, SA 
treatment was found to lower total cholesterol levels in the 
liver and kidney of l-NAME spontaneously hypertensive 
rats. Docking studies revealed that this effect was due to 
the repression of endogenous cholesterol biosynthesis by 
inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-
CoA) reductase (Silambarasan et al., 2016).
Anti-diabetes activity
Diabetes is a group of “heterogeneous, hormonal and metabolic 
disorders”, with hyperglycaemia being one of its physiological 
characteristics. Type 2 diabetes (T2D), in particular, is one 
of the most prevalent “metabolic pathologies” worldwide, 
with >220 million people affected. Chronic hyperglycaemia 
has detrimental cellular effects, as oxidation of glucose as 
well as protein glycation and glycoxidation all enhance the 
formation of ROS. The biochemical and physiological effects 
of SA treatment on streptozotocin (STZ)-induced diabetic 
rats revealed that oral administration of SA was found to 
cause a significant improvement in body weight, attributed 
to the anti-hyperglycaemic effect of SA (Stumvoll et al., 
2005). SA also influenced other physiological parameters, 
such as decreasing kidney weight to near-normal values. 
SA significantly decreased plasma glucose when compared 
to diabetic control rats, which the authors suggest could be 
due to the regeneration of existing pancreatic β-cells by SA 
and enhanced transport of glucose to peripheral tissues. 
SA significantly increased the levels of both C-peptide and 
insulin in STZ-induced diabetic rats, while decreasing the 
level of glycosylated haemoglobin (HbA1c) and increasing the 
level of total haemoglobin. The authors speculate that these 
changes could be due to the reduction of blood glucose level. 
Increased activities of enzymes involved in gluconeogenesis, 
i.e. glucose-6-phosphatase and fructose-1, 6-biphosphatase, 
were observed in the liver and kidney of diabetic rats. SA 
restored their level of activity to near normal, resulting in 
improved glycaemic control (Kanchana et al., 2011).
considered a primary causative factor in colon cancer, via the 
formation of methylazoxymethanol, a metabolite that induces 
the formation of DNA adducts. SA was effective in reducing 
the development of pre-cancerous lesions when studied 
previously (Balaji et al., 2015).
Protective role in cardiovascular disease
Cardiovascular disease is the number one cause of death 
globally and the leading cause of death among Europeans 
(Townsend et al., 2015). The available figures from 2013 
revealed that 30.8% of deaths in the US were due to 
cardiovascular disease (Mozaffarian et al., 2016). Lifestyle 
modifications, including a healthy diet, can play a protective 
role. Although no human studies have been performed, SA 
was shown to have a protective effect on isoproterenol (ISO)-
induced myocardial infarction (MI) in rats. MI induction with 
ISO is a well-established animal model used to evaluate 
the effects of various cardioprotective agents because 
the pathophysiological changes are analogous to those 
taking place in humans with MI. Pre- or co-treatment with 
SA normalised the activity of serum creatine kinase (CK-
MB), suggesting that SA protects the heart and reduces 
the damage leading to leakage of CK-MB. SA normalised 
the levels of lipid peroxidation products, such as cardiac 
malondialdehyde, and as such, apparently inhibited oxidative 
stress and stabilised lysosomal membranes. In accordance 
with this finding, SA normalised lysosomal enzymes including 
β-glucuronidase and β-galactosidase, as well as cathepsins 
B and D. Co-treatment with SA also reduced the size of the 
infarct, protecting the heart from ISO-induced MI (Roy and 
Prince, 2012).
Reperfusion injury occurs due to ischaemia followed by 
reintroduction of blood flow to a previously ischaemic tissue, 
causing additional myocardial damage and cardiac contractile 
dysfunction (Silambarasan et al., 2015). As oxidative stress 
is an important contributor to ischaemia/reperfusion (I/R) 
injury, antioxidants have been considered as a potential 
therapeutic option (Yang et al., 2013). Oral pre-treatment with 
SA significantly improved the percent rate–pressure product 
and percent coronary flow when compared to untreated I/R 
hearts. Mitochondrial dysfunction results in cardiac contractile 
dysfunction and hypertrophy; moreover, under conditions of 
oxidative stress, the enzymes of the tricarboxylic acid (TCA) 
cycle are disrupted. Decreases in the activity of several 
TCA enzymes were blunted after pre-treatment with SA. SA 
was also found to reduce H9c2 cardiomyoblast cell injury 
caused by H
2O2, probably due to its scavenging abilities 
(Silambarasan et al., 2015).
In Nω–nitro-l-arginine methyl ester hydrochloride (l-NAME)-
treated rats, SA decreased the mean arterial pressure, along 
with kidney and liver weights. SA increased the activities of 
the antioxidant enzymes SOD and CAT, along with the levels 
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Trolox and BHT. It was found that PCA generally exhibited 
higher inhibition levels than Trolox, but not BHT, in terms of 
scavenging of superoxide anion and hydroxyl radical. The 
generally lower IC50 values obtained for PCA in comparison 
to the positive controls Trolox and BHT indicate that PCA is 
a better antioxidant, as a lower IC50 value indicates higher 
antioxidant activity. The DPPH and ABTS assays were 
conducted in organic solutions, while the reducing power 
(Fe3+ and Cu2+) and superoxide anion- and hydroxyl radical-
scavenging assays were carried out in aqueous solutions. 
Therefore, PCA exhibited significant antioxidant abilities in 
both lipidic and aqueous media and is thus considered an 
ideal natural antioxidant in both media (Li et al., 2011). The 
potent antioxidant activity of PCA was also shown in ageing 
rats. Treatment with PCA caused a significant rise in the 
enzymatic activities of CAT and GSH peroxidase (GSH-PX), 
both of which are endogenous enzymatic antioxidants (Zhang 
et al., 2011). This highlights the therapeutic potential for PCA 
in the treatment of age-associated disorders, such as cancer, 
through decreasing the levels of harmful ROS.
HDAC inhibition
Khaopha et al. (2015) obtained phenolic-rich testa extracts 
from peanut testae (skins), which were found to possess 
HDAC inhibitory activity and anti-cancer activity. PCA and 
p-coumaric acid were found to be the most predominant 
phenolic acids, with the highest quantity of PCA in the 
ICG15042 extract, while SA was greater in the KK4 
extract (Khaopha et al., 2015). HeLa cells treated with 
the phenolic-rich testa extracts ICG15042, KS2 and KK4 
displayed a significant increase in all four acetylated lysine 
residues of histone H4, indicating HDAC inhibition. The 
authors suggested that some of the phenolic compounds 
in the extracts were functioning as HDAC inhibitors, with 
extracts ICG15402 and KK4 chosen for further evaluation 
as they displayed the highest HDAC inhibitory activity. Both 
extracts significantly inhibited the proliferation of various 
human cancer cell lines, including HeLa (human cervical 
adenocarcinoma), HT29 (human colon adenocarcinoma), 
HCT116 (human colorectal carcinoma) and Jurkat (human 
T-cell leukaemia) cells, with Jurkat cells being particularly 
sensitive to this anti-proliferative activity. Both extracts 
induced apoptosis in the cancer cell lines; however, it 
appeared that apoptotic induction was most effective in 
the HeLa and HCT116 cells, a result also observed by 
Senawong et al. (2013). Importantly, when the extracts were 
tested with a non-cancer cell line, the number of apoptotic 
cells was similar to that with the solvent control, indicating 
that the phenolic extracts were not harmful to normal cells 
(Khaopha et al., 2015). This is crucial given that specificity is 
a vital attribute to any therapeutic agent, in order to minimise 
damage to healthy cells and reduce side effects.
SA can directly influence glucose utilisation, by significantly 
lowering postprandial glucose without altering plasma insulin 
levels. Glucose transporter type 4 (GLUT4) expression was 
significantly increased in the soleus muscle of STZ-induced 
rats, with SA causing a concentration-dependent increase in 
glucose uptake in the soleus muscle. This was confirmed in 
L6 myoblast cells, indicating that SA may directly stimulate 
glucose uptake. In vivo, SA increased insulin sensitivity, 
probably due to the enhanced glucose uptake in skeletal 
muscle (Cherng et al., 2013). Taken together, these results 
indicate that SA may be clinically useful in the treatment of 
diabetes.
Anti-inflammatory activity
Nuclear transcription factor kappa-B (NF-κB) plays a key 
role in the pathogenesis of inflammation, and as such, there 
are numerous drugs designed to treat inflammatory disease, 
which are based on the inhibition of NF-κB, e.g. non-steroidal 
anti-inflammatory drugs. In response to lipopolysaccharide 
(LPS), SA inhibited the expression levels of inducible nitric 
oxide synthase (iNOS) and cyclooxygenase (COX)-2, which 
were markedly upregulated (Yun et al., 2008). The mRNA 
levels of both iNOS and COX-2 were also reduced, indicating 
transcriptional inhibition. SA reduced the production of tumour 
necrosis factor (TNF)-α and interleukin (IL)-1β, as well as their 
mRNA expression levels. RAW 264.7 cells treated with SA 
had a reduction in the DNA-binding activity of p65, preventing 
transcription initiation by NF-κB and subsequent expression 
of genes involved in the immune response (Schmitz and 
Baeuerle, 1991; Pahl, 1999). The nuclear translocation of 
both p65 and p50 was also inhibited. Another key finding was 
SA’s ability to inhibit the LPS-induced degradation of I kappa 
B-alpha (IkB-α), preventing the release of NF-κB. These 
results demonstrate that SA inhibits iNOS, TNF-α, COX-2 and 
IL-1β expression, and this is at least partly mediated via an 
NF-κB mechanism. This anti-inflammatory activity was also 
demonstrated in vivo, with SA inhibiting oedema caused by 
acute inflammation in serotonin- and carrageenan-induced rat 
paw oedema models (Yun et al., 2008).
Properties of PCA
Antioxidant activity of PCA
The physiological effect of PCA is believed to be linked to 
its antioxidant activities, which were recently investigated 
in vitro. DPPH and 2,2′-azino-bis-3-ethylbenzthiazoline-6-
sulphonic acid (ABTS) assays demonstrated that PCA had 
better scavenging activity than the positive controls Trolox 
and butylated hydroxytoluene (BHT). When compared to 
Trolox and BHT in terms of reducing power percentage (%-
Fe3+ and %-Cu2+), PCA was found to be much more efficient. 
PCA also had lower half-maximal inhibitory concentration 
(IC50) values for both Fe3+ and Cu2+ assays, in comparison to 
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LLC-PK1 cells in vitro, while in vivo studies showed that PCA 
prevented cisplatin-induced increase in the renal function 
marker, creatine. Cisplatin treatment also resulted in distinct 
histopathological changes in the rat kidney, such as tubular 
epithelial cellular necrosis, desquamation, vacuolisation and 
swelling. PCA treatment caused notable improvement in the 
histological appearance, with reduced tubular cell damage 
and swelling, providing almost “complete renoprotection” 
(Yamabe et al., 2015).
Anti-metastatic activity
Metastasis accounts for almost 90% of cancer-associated 
mortality and is the biggest problem in the clinical treatment 
and management of cancer. PCA represents a potentially 
important agent for those patients who are diagnosed with 
early cancer lesions, as the anti-metastatic effects of PCA 
could stop the subsequent dissemination from the primary 
tumour and prevent metastasis in those patients (Chaffer 
and Weinberg, 2011). The metastasis process is still poorly 
understood, and there is an urgent need to develop new 
therapeutic strategies and targets to prevent or inhibit 
this phenomenon. The anti-metastatic potential of PCA in 
the highly metastatic melanoma cell line B16/F10 and in 
human gastric carcinoma AGS cells was also demonstrated 
previously. PCA inhibited the secretion of MMP-2 in human 
gastric carcinoma AGS cells and inhibited the protein kinase 
B (Akt)/NF-κB/MMP-2 pathway via the activation of RhoB. 
Metastasis of the B16/F10 melanoma cells to the liver of C57/
BL6 mice was also considerably reduced by PCA treatment 
(Lin et al., 2011).
Anti-inflammatory activity
Studies have demonstrated the ability of PCA to inhibit the 
LPS-induced secretion of pro-inflammatory cytokines, such 
as IL-8, IL-2 and chemokine (C-C motif) ligand-2 (CCL2), 
from monocyte-derived dendritic cells and human gingival 
fibroblasts via activation of peroxisome proliferator-activated 
receptor (PPAR)-g. As cytokines such as IL-8 and CCL2 are 
involved in recruiting inflammatory cells, a reduction in the 
IL-8 content in the extracellular environment may limit the 
recruitment of inflammatory cells and thus prevent the initiation 
of an inflammatory immune response (Del Corno et al., 2014; 
Wang et al., 2015b). PCA can also prevent inflammation by 
inhibiting the oxidation of fatty acids, which are activators 
of PPAR-g signalling (Nagy et al., 1998). The pathology 
of neurodegenerative diseases, including Parkinson’s 
and Alzheimer’s disease (AD), has been attributed to the 
overproduction of inflammatory mediators such as TNF-α, 
IL-6 and IL-1β. These inflammatory mediators are produced 
following the activation of microglia, which are immune cells 
resident in the brain, by LPS, and the subsequent activation 
of NF-κB and MAPKs. As such, regulating the activity of 
Anti-cancer activity
Cytotoxicity
PCA is cytotoxic to various cancer cell lines, including 
human breast MCF-7 cells, lung cancer A549 cell, HepG2 
hepatocellular carcinoma, cervix HeLa and prostate cancer 
LNCaP cells. PCA was able to penetrate the cancer cells, 
destroying the integrity of the plasma membrane, causing 
apoptosis and lactate dehydrogenase (LDH) leakage. PCA 
also decreased Na+/K+-ATPase activity, thereby disrupting 
ion homoeostasis, resulting in collapse of the mitochondrial 
membrane. This collapse resulted in the release of pro-
apoptotic factors, initiating the intrinsic apoptotic pathway, 
and was also suggested to cause an increase in the activities 
of caspase-8 and -3, which are key mediators of apoptosis 
(Yin et al., 2009). PCA also displayed cytotoxicity against 
non-small cell lung cancer via similar mechanisms as 
reported herein. They found that PCA induced mitochondrial 
dysfunction and apoptosis through increases in Bax and 
caspase-3 expression and a decrease in Na+/K+-ATPase 
activity. PCA also modulated several signalling pathways, 
including FAK, MAPK and NF-κB pathways and thus reduced 
the release of inflammatory cytokines such as IL- 6 and 
IL-8. Production of proteins involved in metastasis (such 
as basic fibroblast growth factor [bFGF] and the matrix 
metalloproteinases MMP-2 and MMP-9) were also reduced 
(Tsao et al., 2014).
Chemoprevention and reduced side effects
Cancer chemoprevention can be defined as the prevention 
of cancer using non-toxic synthetic chemicals or chemicals 
from natural substances before malignancy occurs. PCA was 
previously shown to prevent oral carcinogenesis, reducing 
incidences of neoplasms in the tongue (squamous cell 
papilloma and carcinoma), along with significantly decreasing 
pre-neoplastic lesions (hyperplasia and dysplasia) (Tanaka 
et al., 1994). Anthocyanins derived from black raspberries, 
along with the main anthocyanin metabolite PCA, were 
studied in N-nitrosomethylbenzylamine (NMBA)-induced 
oesophageal tumours in rats. PCA delayed the formation of 
pre-neoplastic lesions and the progression of these lesions to 
papillomas, ultimately reducing NMBA-induced oesophageal 
carcinogenesis. PCA also induced the expression of PTX3, 
which was shown to possess anti-angiogenic and anti-
tumourigenic activity in prostate cancer cells (Peiffer et al., 
2014).
Although cancer prevention is crucial, improving existing 
therapies and reducing harmful side effects is just as vital. 
Cisplatin is widely used to treat various solid malignancies; 
however, its use is limited due to its associated nephrotoxicity, 
which primarily occurs in kidney proximal tubule epithelial 
cells (Karasawa and Steyger, 2015). PCA was found to 
prevent induced oxidative damage in kidney proximal tubule 
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rats could be due to the antioxidant activity of PCA, given that 
it has been postulated that oxidation plays a role in vascular 
impairment in diabetes. The potential of PCA to prevent or limit 
cardiac complications in diabetes was demonstrated earlier 
using type 1 diabetic rats by Semaming et al. (2014), who 
found that PCA reduced MDA levels, along with attenuating 
mitochondrial depolarisation, decreasing mitochondrial 
swelling and attenuating mitochondrial ROS production. PCA 
in combination with insulin could restore echocardiography to 
a normal status, which could not be achieved by insulin alone. 
HbA1c levels were also reduced, indicating greater long-term 
glycaemic control. Cardiac apoptosis is a poor predictor of 
outcome in those with cardiac disease or heart failure. In line 
with this, PCA increased the anti-apoptotic protein Bcl2 in the 
heart tissue of diabetic rats (Semaming et al., 2014). 
Currently, there is a need for anticoagulation agents from 
natural sources in the clinic. In addition, the anti-thrombotic 
potential of PCA derived from fermented pine needles was 
evaluated. The processes of coagulation and anticoagulation 
are tightly regulated, and an imbalance in this process can 
lead to thrombus formation, which adheres to blood vessel 
walls. If this thrombus is not broken down, circulation is 
interrupted, leading to high blood pressure, stroke, ischaemic 
heart disease and myocardial infarction. PCA was tested for 
its fibrinolysis activity, by measuring the turbidity in a fibrin 
clot solution. PCA caused a dramatic decrease in turbidity, 
indicating that the fibrin clot had dissolved. Further studies 
aimed to elucidate the mechanism behind the fibrinolytic 
activity of PCA. A pH range of 2–4 was optimal for PCA to exert 
its fibrinolytic activity. At this acidic pH, PCA mainly exists in a 
non-ionised form, therefore allowing it to form greater number 
of hydrophobic interactions. The authors suggested that this 
increased tendency towards hydrophobic interactions allows 
enhanced binding between PCA and polypeptide chains, 
compromising their stability and causing “loosening of the 
fibrin network”. The authors concluded that PCA exerted its 
fibrinolytic activity through a “dissolving effect”, rather than by 
degradation of fibrin and fibrinogen. In vivo, PCA was shown 
to significantly inhibit thrombosis induced by carrageenan in 
mouse tail when compared to the control. In FeCl
3-induced 
carotid arterial thrombus model experiments, rats treated with 
PCA had no thrombus formation, indicating that PCA could 
inhibit vascular obstruction (Park et al., 2016a).
Anti-diabetes activity
Functional foods provide a promising alternative therapeutic 
strategy to drive positive metabolic changes that would impair 
the T2D process; however, few studies have elucidated the 
molecular mechanisms of polyphenols on insulin signalling. A 
recent study (Scazzocchio et al., 2011) has shown that PCA 
is able to partially counteract the loss of insulin sensitivity 
in T2DM and activate the insulin receptor substrate-1/
the microglia could be a potential therapeutic strategy. In 
accordance with this observation, Wang et al. (2015) found 
that PCA could inhibit the inflammatory mediators TNF-α, IL-
1β, IL-6 and prostaglandin-2 (PGE2) but could also inhibit 
the LPS-induced activation of NF-κB and MAPKs, both of 
which are key regulators of inflammatory cytokine production. 
Another key finding was PCA’s ability to inhibit the expression 
of Toll-like receptor 4 (TLR4), a receptor that activates NF-
κB and MAPKs upon stimulation by LPS. This, therefore, 
suggests that PCA exerts its anti-inflammatory effects 
through inhibition of the TLR4 pathway, making it a potential 
candidate to regulate the activation of microglia in order to 
treat neurodegenerative diseases (Wang et al., 2015a).
A recently published study has identified PCA as a potential 
therapeutic agent in the treatment of inflammatory bone 
disease. Osteoclasts are necessary for bone matrix 
degradation and to initiate bone re-modelling. However, an 
imbalance in their activity can lead to bone deterioration, 
which is a symptom of diseases such as osteoporosis and 
rheumatoid arthritis. M-CSF and RANK-L are potent inducers 
of mature osteoclasts, with RANK-L activating transcription 
factors such as c-Fos, which activate osteoclasts and induce 
their differentiation. PCA was found to inhibit RANK-L-induced 
c-Fos protein expression, while also inhibiting the differentiation 
of osteoclasts in mouse bone marrow macrophages. The 
bone-resorbing ability of mature osteoclasts was also inhibited. 
In vivo, PCA was shown to have a protective effect against 
LPS-induced bone loss. PCA was also found to downregulate 
the expression of osteoclastogenesis-related genes, including 
DC-STAMP and b3-integrin (Park et al., 2016b).
Protective role in cardiovascular disease
The co-morbidities associated with diabetes pose serious 
health risks, with vascular complications being the primary 
cause of mortality and morbidity in those suffering from 
chronic diabetes. The effects of PCA on vascular responses in 
chronically diabetic rats were also examined. PCA was found 
to protect blood vessels by increasing nitric oxide production, 
which prevents the interaction of platelets and leucocytes with 
the vascular cell wall. Hypertension is a common complication 
of diabetes. PCA was found to cause significant reductions in 
the high diastolic, systolic and mean arterial blood pressures 
observed in chronically diabetic rats. PCA also ameliorated 
diabetes-induced high blood pressure by restoring the 
reduced vascular reactivity in the diabetic rats (Semaming 
et al., 2016). This improved reactivity was exemplified by the 
restoration of the vasoconstriction and vasodilation responses 
following PCA treatment. PCA treatment also caused a 
decrease in the oxidative stress marker malondialdehyde 
(MDA), while the activities of the antioxidant enzymes SOD 
and CAT were increased. The authors, therefore, suggested 
that the improved vascular reactivity observed in the diabetic 
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For patients suffering from neurodegenerative brain diseases, 
ameliorating symptoms is crucial. PCA was found to improve 
cognitive defects in a mouse model of AD and attenuate Ab 
deposition, which is a hallmark of AD (Song et al., 2014). 
Inflammatory events in AD result from an imbalance in the 
formation and clearance of Ab, with mounting evidence that 
Ab accumulation is linked to the secretion of inflammatory 
cytokines. PCA reduced the levels of TNF-α, IL-1β, IL-6 and 
IL-8 in AbPP/PS1 mice. Although the underlying mechanism 
behind PCA’s effect on Ab-induced neurotoxicity was 
not elucidated, it is attributed to its antioxidant and anti-
inflammatory activities. Crucially, PCA displayed similar anti-
inflammatory activity as donepezil, a cholinesterase inhibitor 
used to treat AD.
Protection against nephrotoxicity and hepatotoxicity
Cadmium (Cd) is a heavy metal that is a by-product of zinc 
production. It is considered to be one of the most toxic 
environmental and industrial pollutants. It can be ingested 
from foods, drinking water and contaminated soil or through 
cigarette smoking. The kidney is the most affected by 
prolonged low-level exposure to Cd, causing proteinuria, 
calciuria and tubular necrosis, all of which may result in end-
stage renal failure, diabetic complications and osteoporosis. 
Cd can also lead to nephrotoxicity due to its tendency to settle 
in the proximal tubule of the nephron, although the underlying 
mechanism is yet to be fully elucidated. PCA can attenuate 
the nephrotoxicity and hepatotoxicity induced by Cd in rats. 
Treatment with Cd led to “severe” hepatic damage, evidenced 
by the increased activity of the hepatic enzymes alanine 
transaminase (ALT), AST and ALP in the serum of the Cd-
induced hepatotoxicity group compared to the normal control. 
Co-treatment with PCA was found to ameliorate the activities 
of these hepatic enzymes. Crucially, PCA at doses of 10 and 
20 mg/kg had no adverse effects on the rats (Adefegha et al., 
2015).
Potential use of SA and PCA recovered from rape-
seed meal
SA and PCA may improve human health, and both 
compounds are present in traditional Chinese medicines, 
such as “Yinhuang powder” and Salvia miltiorrhiza (also 
known as Danshen) (Wen et al., 2005; Cao et al., 2014; Su 
et al., 2015). Research on these phenolic compounds has 
suggested that they possess diverse bioactive properties, 
including anti-cancer, anti-diabetes and anti-inflammatory 
activities, in addition to a role in the prevention and treatment 
of cardiovascular and neurodegenerative diseases (Yun 
et al., 2008; Balaji et al., 2015; Ju et al., 2015; Semaming 
et al., 2016; Talagavadi et al., 2016). Given these potent 
phosphatidylinositol 3-kinase/Akt (IRS-1/PI3K/Akt) signalling 
pathway, leading to increased glucose uptake. In adipocytes, 
PCA was found to be dependent on activation of the entire 
insulin pathway, as inhibition of the major players in the 
insulin signalling cascade IRS-1, PI3K or Akt prevented 
glucose uptake and GLUT4 translocation. PCA has also 
been reported to enhance glucose uptake by increasing 
translocation of GLUT4 to the cell membrane or, additionally, 
by increasing adiponectin secretion, a protein hormone 
capable of modulating glucose and fatty acid metabolism 
(Scazzocchio et al., 2011).
The effects of PCA on adenosine monophosphate (AMP)-
activated protein kinase (AMPK) activation and the role 
of PCA in glucose homoeostasis in mice were examined 
previously (Talagavadi et al., 2016). AMPK is involved in 
metabolic regulation and was reported to be central to the 
control of glucose metabolism. In contrast, mammalian target 
of rapamycin (mTOR) and S6K1 are known to play a role in 
insulin resistance. It was found that PCA could significantly 
activate AMPK, although indirectly, and downregulate S6K in 
mouse livers. Upon intraperitoneal administration of glucose, 
there was a significant decrease in the glucose level in PCA-
treated mice, with similar results obtained for the positive 
control metformin, indicating that PCA can induce glucose 
tolerance. In obese mice, pre-treatment with PCA significantly 
reduced hyperglycaemia after glucose injection. Furthermore, 
the insulin tolerance test showed that PCA administration 
amplified the glucose decrease, indicating that PCA improved 
insulin sensitivity in obese mice (Talagavadi et al., 2016).
Protective neurological effects
In order to repair injured nerves in adults, proliferation of 
nerve cells is a vital process. Schwann cells are crucial 
for the function and regeneration of neurons, and it was 
recently demonstrated that PCA could stimulate Schwann 
cell proliferation and survival by phosphorylating the insulin-
like growth factor-I (IGF-I)-mediated PI3K/Akt pathway (Ju 
et al., 2015). PCA enhanced the proliferation of RSC96 cells, 
inducing cell cycle progression at the G1-to-S phase. An 
increase in cyclin A was observed, resulting in the promotion 
of DNA replication and growth of RSC96 cells. A phenomenon 
that is vital to the repair and regeneration process of nerves 
is the migration of RSC96 Schwann cells along the growth 
direction. It was found that PCA enhanced Schwann cell 
migration, and that the IGF-1/Akt/PI3K pathway may play a 
key role in this process. The results of that study highlight the 
potential utility of PCA in the treatment of peripheral nerve 
injuries caused by trauma, surgery or acute compression. 
Guan et al. (2009) also demonstrated the ability of PCA to 
stimulate proliferation of rat hippocampal neural stem cells, 
which are believed to contribute to the regenerative potential 
of the adult central nervous system.
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of phenolics, including SA and PCA. Such systems were 
found to increase the phytochemical absorption of phenolic 
compounds in epithelial cells (Dias et al., 2015). The increased 
bioavailability of resveratrol following micro-encapsulation is 
proof of the efficacy of this technique (Davidov-Pardo and 
McClements, 2014). Utilising SA and PCA as functional food 
ingredients allows validation of a rapeseed by-product and 
its potent bioactive phenolics. Phenolic compounds have 
previously been encapsulated using methods such as spray-
drying, extrusion and atomisation/coagulation. Spray-drying 
is a very straightforward and common micro-encapsulation 
method used in the food industry. Carbohydrate polymers 
such as starch and cellulose are commonly used as the 
shell material and are good candidates as they are generally 
recognised as safe (GRAS) (Dias et al., 2015). A recent in 
vitro study demonstrated the great potential to successfully 
encapsulate PCA for functional food purposes. Madureira et al. 
(2016) investigated chitosan nanoparticles “loaded” with PCA 
for potential incorporation into food matrices or as functional 
food ingredients. The study found that the best nanoparticle 
for PCA was a low-molecular-weight nanoparticle, and the 
encapsulation process did not diminish the antioxidant activity 
of PCA. It was found that the nanoparticles could bypass 
the acidic environment of the stomach intact and reach 
the intestine, where the neutral pH results in “coagulation/
flocculation” of the chitosan nanoparticle and release of the 
phenolics. From the intestine, the phenolics can be absorbed 
into the bloodstream (Madureira et al., 2016). Ultimately, 
validating this rapeseed by-product and its bioactive 
compounds for use in food, cosmetic and pharmaceutical 
industries depends on successful clinical trials. Currently, 
there are no clinical studies examining the bioavailability or 
bioactivity of phenolic acids from rapeseed, including SA and 
PCA. However, a search of Clinicaltrials.gov revealed that 
there have been trials on phenolic acids from other sources 
such as black tea, oat and purple wheat products in terms of 
their pharmacokinetics and bioavailability.
Conclusion
Phenolic compounds such as SA and PCA hold great 
promise due to their purported bioactive properties, 
including anti-diabetes, anti-cancer and anti-inflammatory 
activities, in addition to possessing a protective role in AD 
and cardiovascular disease. Various traditional methods are 
used to extract these phenolics from rapeseed meal, based 
on both solvents and enzymes. However, there are issues 
associated with these methods, including the requirement 
for large volumes of solvents and their associated toxicities. 
The need for simpler, more efficient methodologies has led 
to the development of novel techniques, such as ultrasound-
bioactivities and the fact that rapeseed is a rich source of 
phenolic compounds, optimising methods to isolate these 
compounds from rapeseed meal is pertinent. SA and PCA 
in dietary sources are present in insufficient quantities to 
exert a sufficient physiological effect (Nunez-Sanchez et al., 
2015). Therefore, optimal extraction of these phenolics from 
rapeseed meal would allow them to be used as functional 
food ingredients and exert their physiological effects through 
dietary intake. The antioxidant properties of these phenolics 
would make them useful in the cosmetic industry, and indeed, 
a patent was filed regarding the use of SA as a cosmetic 
ingredient, such as in a topical agent to protect against the 
signs of skin ageing (Markert et al., 2011).
Bottlenecks concerning the use of SA and PCA re-
covered from rapeseed meal
The stability and bioavailability of rapeseed phenolics is an 
issue in terms of the biorefining process and total utilisation 
of the rapeseed crop (Nićiforović and Abramovič, 2014; 
Dias et al., 2015). Phenolic compounds are susceptible to 
spontaneous oxidation and degradation (Tan et al., 2011). 
Oxidation may occur through enzymatic or non-enzymatic 
reactions, resulting in oxidation products that are “nutritionally 
unavailable” (Shahidi and Naczk, 1992). Phenolics can also 
interact with minerals, such as iron, and inhibit their absorption, 
and the metabolism of phenolics by phase II enzymes also 
leads to poor bioavailability (Vuorela, 2005; De Souza et al., 
2015). Bioavailability is a key issue, given that little is known 
about the metabolism of SA and PCA. The epithelium of the 
small intestine plays a role in the bioavailability and metabolism 
of SA, involving both phase I and phase II metabolic enzymes; 
however, compared to other hydroxycinnamic acids such 
as ferulic acid, little is known about the metabolism of SA 
(Nićiforović and Abramovič, 2014). A recent bioavailability 
study with rats fed the herb Polygonum capitatum found that 
PCA was primarily distributed in the kidney tissue, followed 
by the lung tissue; however, >80% was excreted (Ma et al., 
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micro-dialysates, indicating that it could cross the blood–brain 
barrier.
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sulation: designing delivery systems to overcome solubility, stabil-
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Del Corno, M., Varano, B., Scazzocchio, B., Filesi, C., Masella, R. and 
Gessani, S. 2014. Protocatechuic acid inhibits human dendritic 
cell functional activation: role of PPARgamma up-modulation. Im-
munobiology 219: 416–424.
Dias, M.I., Ferreira, I.C.F.R. and Barreiro, M.F. 2015. Microencap-
sulation of bioactives for food applications. Food & Function 6: 
1035–1052.
Dubie, J., Stancik, A., Morra, M. and Nindo, C. 2013. Antioxidant 
extraction from mustard (Brassica juncea) seed meal using high-
intensity ultrasound. Journal of Food Science 78: E542–E548.
Galano, A., Francisco-Marquez, M. and Alvarez-Idaboy, J.R. 2011. 
assisted, microwave-assisted, HVED and PEF extractions. 
Development of these novel techniques allows the validation 
of a rapeseed by-product and total utilisation of the rapeseed 
crop without generating waste. It must be noted that further 
optimisation and validation of these techniques are necessary 
with regard to isolating phenolic compounds from rapeseed 
meal.
In order to utilise the phenolic compounds isolated from 
rapeseed meal, there are issues that need to be addressed. 
The two major issues are stability and bioavailability, which 
could hinder the use of the phenolics in food and cosmetic 
industries. A solution is the micro-encapsulation of the 
phenolics, and initial studies have shown the efficacy of 
this technique, which would make the phenolics suitable 
for food applications. Ultimately, maximising the use of 
rapeseed meal phenolics depends on proven clinical safety 
and efficacy. To date, there are no clinical trials regarding 
rapeseed phenolics, including SA and PCA; however, there 
are clinical trials regarding the use of phenolic compounds 
from other sources.
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